MCRB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seres Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.75 USD -10.26% Market Closed

Market Cap: $16.9m

	Seres Therapeutics Inc NASDAQ:MCRB	US
	Neste Oyj OTC:NTOIF	FI
	Aura Energy Ltd OTC:AUEEF	AU
	Janus Living Inc NYSE:JAN	US
	Spyrosoft SA F:2NP	PL
D	Daewon Cable Co Ltd KRX:006345	KR
A	American Eagle Outfitters Inc SWB:AFG	US
	Tauns Laboratories Inc TSE:197A	JP
	Relo Group Inc F:665	JP
	Prosus NV F:1TY	NL
S	Sibanye Stillwater Ltd JSE:SSW	ZA
M	Mycron Steel Bhd KLSE:MYCRON	MY
A	AMETEK Inc F:AK1	US
M	MK Exim (India) Ltd BSE:538890	IN

Profitability Summary

Seres Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4.154%

Negative 3Y Average Operating Margin

-10.645%

Declining Operating Margin

-55% > -4.154%

Negative Net Margin

-1.193%

Negative 3Y Average Net Margin

-618%

Declining Net Margin

-112% > -1.193%

Negative Free Cash Flow Margin

-2.724%

Negative 3Y Average Free Cash Flow Margin

-2.606%

Declining Free Cash Flow Margin

-106% > -2.724%

Negative ROE

-67%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-81%

Declining ROIC

-54% > -86%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.